ArticleBMC surgery2025
Partial splenectomy and pericardial devascularization for symptomatic patients with portal hypertension: a single-center retrospective study.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of an interpretable machine learning model for predicting portal vein system thrombosis following splenectomy in Wilson's disease.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe dilemma of current treatments for symptomatic patients with portal hypertension is how to resolve the problems of the varices and hypersplenism simultaneously and meanwhile preserve the splenic function. Partial splenectomy and pericardial devascularization is a potential alternative to currently used approaches, but it is incompletely defined. This study aimed to evaluate the efficacy and safety of partial splenectomy and pericardial devascularization.
methodsThis study followed 132 symptomatic patients with portal hypertension who underwent partial splenectomy and pericardial devascularization in the General Surgery Department of the Fifth Medical Center of PLA General Hospital from 2016 to 2023. Clinical, laboratory, endoscopic examination and imaging data were collected and compared between preoperative and postoperative levels at intervals using a mixed linear model.
resultsAll 132 patients with portal hypertension successfully underwent partial splenectomy and pericardial devascularization without intraoperative uncontrolled massive bleeding or death. Leucocyte and platelet counts increased to normal levels at intervals from 1 year to ≥ 4 years postoperatively. Among the patients followed for six months postoperatively, 23 (52.27%) showed improvement in esophagogastric varices, 19 (43.18%) had no significant changes in their condition, and 2 (4.55%) experienced worsening of the varices. At subsequent follow-ups, the majority of patients either showed improvements or no change in their esophagogastric varices, with only a small fraction experiencing worsening of the condition. The splenic remnant survived in most patients, and regrowth was very limited postoperatively, while 13 (9.85%) patients splenic remnant necrosis during follow-up. Liver failure was observed in 5 (3.79%) patients postoperatively, and 3 (2.27%) of them died perioperatively. Portal vein thrombosis was found in 90 (75%) patients the 7th days after surgery. With the progression of follow-up time, the proportion of patients with postoperative portal vein system thrombosis decreased over time. 3 (2.27%) patients experienced postoperative abdominal bleeding, which improved after emergency surgery for hemostasis.
conclusionsPartial Splenectomy and Pericardial Devascularization appears to be a safe and effective approach to treat symptomatic patients with Portal Hypertension, while preserving the potential function of the spleen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.